Insiders / Debbane Raymond / Activity
Activity — Debbane Raymond
11 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Jun 3, 2026 | Exercise | LXRX Lexicon Pharmaceuticals, Inc. Common Stock | $0 | +89K +4.69% | 1,995,498 0.45% of shares | low |
| Feb 25, 2026 | Buy | LXRX Lexicon Pharmaceuticals, Inc. Common Stock | $3.0K | +2K +0.10% | 1,906,186 0.43% of shares | low |
| Feb 19, 2026 | Buy | LXRX Lexicon Pharmaceuticals, Inc. Common Stock | $72.0K | +50K +3.02% | 1,704,186 0.38% of shares | medium |
| Feb 13, 2026 | Buy | LXRX Lexicon Pharmaceuticals, Inc. Common Stock | $75.9K | +58K +4.18% | 1,443,641 0.32% of shares | medium |
| Feb 17, 2026 | Buy | LXRX Lexicon Pharmaceuticals, Inc. Common Stock | $100.5K | +77K +5.32% | 1,520,498 0.34% of shares | medium |
| Feb 23, 2026 | Buy | LXRX Lexicon Pharmaceuticals, Inc. Common Stock | $147.0K | +100K +5.54% | 1,904,186 0.43% of shares | medium |
| Feb 20, 2026 | Buy | LXRX Lexicon Pharmaceuticals, Inc. Common Stock | $147.8K | +100K +5.87% | 1,804,186 0.41% of shares | medium |
| Feb 18, 2026 | Buy | LXRX Lexicon Pharmaceuticals, Inc. Common Stock | $176.5K | +134K +8.79% | 1,654,186 0.37% of shares | medium |
| Jun 3, 2026 | Exercise | LXRX Lexicon Pharmaceuticals, Inc. Restricted Stock Units | — | -89K -100.00% | 0 0.00% of shares | low |
| May 1, 2026 | Grant | LXRX Lexicon Pharmaceuticals, Inc. Stock Option (Right to Buy) | — | +43K | 43,478 <0.01% of shares | low |
| May 1, 2026 | Grant | LXRX Lexicon Pharmaceuticals, Inc. Restricted Stock Units | — | +36K | 35,714 <0.01% of shares | low |